B CELL HYPERACTIVITY IN AUTOIMMUNITY
B CELL HYPERACTIVITY IN AUTOIMMUNITY
批准号:
2079040
负责人:
Ann Marshak-Rothstein
金额:
$26.69万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-22 至 2000-03-31
关键词:
B lymphocyte SCID mouse apoptosis autoantibody autoimmune disorder cell population study disease /disorder model gene expression gene mutation genetic strain genetically modified animals immunogenetics immunoregulation laboratory mouse leukocyte activation /transformation leukopoiesis systemic lupus erythematosus
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Mice expressing either of the recessive autosomal mutations, lpr or gld,
develop autoimmune syndromes associated with massive lymphoid hyperplasia
and excessive autoantibody production. Since the range of autoantibody
specificities produced by these mice is similar to that of patients
afflicted with SLE and other systemic autoimmune diseases, they have been
considered a useful model for human disease. The lpr and gld mutations
have recently been mapped to the genes that encode the cell surface
molecules APO-1/Fas and Fas-ligand, respectively. Fas/Fas-ligand
interactions have been shown to be intimately involved in the apoptotic
pathways associated with calcium-independent T cell-mediated cytotoxicity
and peripheral T cell tolerance mechanisms associated with activation
induced cell death. Activated B cells also express the Fas antigen and
studies from this lab and others involving chimeric mice have shown that
in lpr/lpr B cells are inherently different from normal B cells, however
the actual role of Fas/Fas-ligand interactions in conventional B cells
responses is unexplored. The current proposal will address the role of
Fas/Fas-ligand in the regulation of conventional B cell immunity and
attempt to determine why normal B cell survival and function are
suppressed in an [lpr + wildtype] chimeric environment. These issues will
be addressed through the following specific aims: (1) Investigate how
different in vitro activation and cytokine signals regulate Fas and Fas-
ligand expression in T and/or B lymphocyte subpopulations and identify the
cells and conditions that are responsible for in vivo Fas-ligand
expression; (2) Determine the functional consequences of constitutive Fas
expression on B cell survival and function in lpr, gld and +/+ host
environments by producing and analyzing transgenic mice that inherit a B
lineage restricted Fas transgene; (3) Assess the functional properties of
lymphocytes from mice incapable of effectively expressing both Fas and
Fas-ligand, i.e. double mutant lpr/lpr gld/gld ice; and (4) Compare the
germinal center response of normal, lpr, and lpr beta2-microglobulin KO
mice with regard to magnitude, kinetics, antibody diversification, and
affinity maturation. The better understanding of the etiology of
autoimmunity gained from these studies should be directly applicable to
the treatment of human disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
-
批准号:10576930
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2021
-
负责人:Ann Marshak-Rothstein
-
依托单位:
The role of TLRs, Type II IFN and Type III IFN in a Murine Model of Autoinflammation
-
批准号:10375346
-
项目类别:
-
资助金额:$49.49万
-
财政年份:2021
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
-
批准号:9884735
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2019
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Mechanisms by which TLR9-deficiency and FasL Promote Cutaneous Lupus
-
批准号:9752064
-
项目类别:
-
资助金额:$25.13万
-
财政年份:2019
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
-
批准号:9228925
-
项目类别:
-
资助金额:$51.36万
-
财政年份:2015
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Distinct Functional Outcomes of BCR/TLR7 and BCR/TLR9 Co-engagement
-
批准号:9033830
-
项目类别:
-
资助金额:$51.36万
-
财政年份:2015
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Activation of B Cells by Host Toll-Like Receptor Ligands
-
批准号:8504902
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2013
-
负责人:Ann Marshak-Rothstein
-
依托单位:
CO-FUNDING-NIAID
-
批准号:8504901
-
项目类别:
-
资助金额:$130.34万
-
财政年份:2013
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Activation of B Cells by Host Toll-Like Receptor Ligands
-
批准号:8378438
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2012
-
负责人:Ann Marshak-Rothstein
-
依托单位:
CO-FUNDING-NIAID
-
批准号:8378436
-
项目类别:
-
资助金额:$138.54万
-
财政年份:2012
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Activation of B Cells by Host Toll-Like Receptor Ligands
-
批准号:8290052
-
项目类别:
-
资助金额:$0.15万
-
财政年份:2011
-
负责人:Ann Marshak-Rothstein
-
依托单位:
CO-FUNDING-NIAID
-
批准号:8290051
-
项目类别:
-
资助金额:$139.91万
-
财政年份:2011
-
负责人:Ann Marshak-Rothstein
-
依托单位:
CO-FUNDING-NIAID
-
批准号:8153546
-
项目类别:
-
资助金额:$144.64万
-
财政年份:2010
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Activation of B Cells by Host Toll-Like Receptor Ligands
-
批准号:8120844
-
项目类别:
-
资助金额:$0.33万
-
财政年份:2010
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Immunological Mechanisms in Systemic Autoimmune Disease
-
批准号:7671451
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2008
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Immunological Mechanisms in Systemic Autoimmune Disease
-
批准号:8259486
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2008
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Immunological Mechanisms in Systemic Autoimmune Disease
-
批准号:7527648
-
项目类别:
-
资助金额:$35.75万
-
财政年份:2008
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Immunological Mechanisms in Systemic Autoimmune Disease
-
批准号:8015459
-
项目类别:
-
资助金额:$35.83万
-
财政年份:2008
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Immunological Mechanisms in Systemic Autoimmune Disease
-
批准号:7812135
-
项目类别:
-
资助金额:$34.4万
-
财政年份:2008
-
负责人:Ann Marshak-Rothstein
-
依托单位:
Administrative Core
-
批准号:7489207
-
项目类别:
-
资助金额:$5.84万
-
财政年份:2007
-
负责人:Ann Marshak-Rothstein
-
依托单位:
海外基金